TLR4 and pancreatic neoplasm: Small interfering RNA (siRNA)-mediated knockdown of TLR4 or inhibition of TLR4/IL-10 signaling with neutralizing antibodies could reverse the EMT of the pancreatic cancer cells, suggesting that M2-polarized TAMs can promote EMT and aggressive behavior in pancreatic cancer cells [90].